Results for Snake Bites/drug therapy

Publications & Outputs

1. Repurposed drugs and their combinations prevent morbidity-inducing dermonecrosis caused by diverse cytotoxic snake venoms

   Hall, S. R., Rasmussen, S. A., Crittenden, E., Dawson, C. A., Bartlett, K. E., Westhorpe, A. P., Albulescu, L-O., Kool, J., Gutiérrez, J. M. & Casewell, N. R., 14/12/2023, In: Nature Communications. 14, 1, p. 1-15 15 p., 7812.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

2. Two snakebite antivenoms have potential to reduce Eswatini's dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing

   Menzies, S. K., Litschka-Koen, T., Edge, R. J., Alsolaiss, J., Crittenden, E., Hall, S. R., Westhorpe, A., Thomas, B., Murray, J., Shongwe, N., Padidar, S., Lalloo, D. G., Casewell, N. R., Pons, J. & Harrison, R. A., 15/09/2022, In: PLoS Neglected Tropical Diseases. 16, 9, e0010496.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

3. Small Molecule Drug Discovery for Neglected Tropical Snakebite

   Clare, R. H., Hall, S. R., Patel, R. N. & Casewell, N. R., 31/05/2021, In: Trends in Pharmacological Sciences. 42, 5, p. 340-353 14 p.

   Research output: Contribution to Journal/Magazine › Review article › peer-review